Genetically-proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers

James Yarmolinsky, Virginia Díez-Obrero, Tom G Richardson, Marie Pigeyre, Jennifer Sjaarda, Guillaume Paré, Venexia M Walker, Emma E Vincent, Vanessa Y Tan, Mireia Obón-Santacana, Demetrius Albanes, Jochen Hampe, Andrea Gsur, Heather Hampel, Ellen Kampman, Rish K Pai, Mark Jenkins, Steven Gallinger, Graham Casey, Wei Zheng, Christopher I Amos, the International Lung Cancer Consortium, the PRACTICAL consortium, George Davey Smith, Richard M Martin, Victor Moreno
doi: https://doi.org/10.1101/2021.03.11.21252971

Data Availability

This analysis used both restricted and publicly-available summary genetic association data. Further information on applying to access restricted data from this analysis can be obtained by visiting the following websites: GECCO (https://www.fredhutch.org/en/research/divisions/public-health-sciences-division/research/cancer-prevention/genetics-epidemiology-colorectal-cancer-consortium-gecco.html), INTEGRAL-ILCCO (https://ilcco.iarc.fr/) and PRACTICAL (http://practical.icr.ac.uk/blog/).

Back to top
Posted March 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Genetically-proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers
James Yarmolinsky, Virginia Díez-Obrero, Tom G Richardson, Marie Pigeyre, Jennifer Sjaarda, Guillaume Paré, Venexia M Walker, Emma E Vincent, Vanessa Y Tan, Mireia Obón-Santacana, Demetrius Albanes, Jochen Hampe, Andrea Gsur, Heather Hampel, Ellen Kampman, Rish K Pai, Mark Jenkins, Steven Gallinger, Graham Casey, Wei Zheng, Christopher I Amos, the International Lung Cancer Consortium, the PRACTICAL consortium, George Davey Smith, Richard M Martin, Victor Moreno
medRxiv 2021.03.11.21252971; doi: https://doi.org/10.1101/2021.03.11.21252971
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area